Your browser doesn't support javascript.
loading
On-Demand Sildenafil as a Treatment for Raynaud Phenomenon: A Series of n-of-1 Trials.
Roustit, Matthieu; Giai, Joris; Gaget, Olivier; Khouri, Charles; Mouhib, Myriam; Lotito, Adrien; Blaise, Sophie; Seinturier, Christophe; Subtil, Fabien; Paris, Adeline; Cracowski, Claire; Imbert, Bernard; Carpentier, Patrick; Vohra, Sunita; Cracowski, Jean-Luc.
Afiliação
  • Roustit M; Université Grenoble Alpes and Grenoble Alpes University Hospital, Grenoble, France (M.R., O.G., C.K., M.M., A.L., S.B., C.S., A.P., C.C., B.I., P.C., J.C.).
  • Giai J; Université de Lyon and Hospices Civils de Lyon, Lyon, France (J.G., F.S.).
  • Gaget O; Université Grenoble Alpes and Grenoble Alpes University Hospital, Grenoble, France (M.R., O.G., C.K., M.M., A.L., S.B., C.S., A.P., C.C., B.I., P.C., J.C.).
  • Khouri C; Université Grenoble Alpes and Grenoble Alpes University Hospital, Grenoble, France (M.R., O.G., C.K., M.M., A.L., S.B., C.S., A.P., C.C., B.I., P.C., J.C.).
  • Mouhib M; Université Grenoble Alpes and Grenoble Alpes University Hospital, Grenoble, France (M.R., O.G., C.K., M.M., A.L., S.B., C.S., A.P., C.C., B.I., P.C., J.C.).
  • Lotito A; Université Grenoble Alpes and Grenoble Alpes University Hospital, Grenoble, France (M.R., O.G., C.K., M.M., A.L., S.B., C.S., A.P., C.C., B.I., P.C., J.C.).
  • Blaise S; Université Grenoble Alpes and Grenoble Alpes University Hospital, Grenoble, France (M.R., O.G., C.K., M.M., A.L., S.B., C.S., A.P., C.C., B.I., P.C., J.C.).
  • Seinturier C; Université Grenoble Alpes and Grenoble Alpes University Hospital, Grenoble, France (M.R., O.G., C.K., M.M., A.L., S.B., C.S., A.P., C.C., B.I., P.C., J.C.).
  • Subtil F; Université de Lyon and Hospices Civils de Lyon, Lyon, France (J.G., F.S.).
  • Paris A; Université Grenoble Alpes and Grenoble Alpes University Hospital, Grenoble, France (M.R., O.G., C.K., M.M., A.L., S.B., C.S., A.P., C.C., B.I., P.C., J.C.).
  • Cracowski C; Université Grenoble Alpes and Grenoble Alpes University Hospital, Grenoble, France (M.R., O.G., C.K., M.M., A.L., S.B., C.S., A.P., C.C., B.I., P.C., J.C.).
  • Imbert B; Université Grenoble Alpes and Grenoble Alpes University Hospital, Grenoble, France (M.R., O.G., C.K., M.M., A.L., S.B., C.S., A.P., C.C., B.I., P.C., J.C.).
  • Carpentier P; Université Grenoble Alpes and Grenoble Alpes University Hospital, Grenoble, France (M.R., O.G., C.K., M.M., A.L., S.B., C.S., A.P., C.C., B.I., P.C., J.C.).
  • Vohra S; University of Alberta, Edmonton, Alberta, Canada (S.V.).
  • Cracowski JL; Université Grenoble Alpes and Grenoble Alpes University Hospital, Grenoble, France (M.R., O.G., C.K., M.M., A.L., S.B., C.S., A.P., C.C., B.I., P.C., J.C.).
Ann Intern Med ; 169(10): 694-703, 2018 11 20.
Article em En | MEDLINE | ID: mdl-30383134

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Raynaud / Vasodilatadores / Inibidores da Fosfodiesterase 5 / Citrato de Sildenafila Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Raynaud / Vasodilatadores / Inibidores da Fosfodiesterase 5 / Citrato de Sildenafila Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article